Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Dutch study shows why plant-based eating can miss key nutrients

3

Jul 2026

Dutch study shows why plant-based eating can miss key nutrients

A Dutch dietary modeling study found that replacing major animal-based protein sources with plant-based substitutes reduced protein, EAA, vitamin, and mineral intake across age groups. Older adults, adolescents, children, and women were especially vulnerable to shortfalls, highlighting the need for planned substitutions, fortified foods, and age-specific dietary guidance.

Study maps how exercise, sleep, diet, and mood connect in daily life

2

Jul 2026

Study maps how exercise, sleep, diet, and mood connect in daily life

Researchers followed 79 U.S. adults for 70 days and found that daily lifestyle behaviors clustered with positive and negative affect across same-day, next-day, and between-person patterns. Person-specific networks showed that these daily habits and mood links varied widely, suggesting future lifestyle interventions may need to be more personalized.

Foodborne threats demand stronger pandemic planning, review says

2

Jul 2026

Foodborne threats demand stronger pandemic planning, review says

A Perspective review in npj Science of Food argues that pandemics can weaken food safety systems even when the pathogen is not foodborne. The authors call for One Health planning that integrates food safety into pandemic preparedness, surveillance, laboratory capacity, workforce readiness, and regulation.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.